Vildagliptin NOBEL 50 mg, Tabletten - 112 Swissmedic Key 68750002 Registration Holder NOBEL Pharma Schweiz AG Name Vildagliptin NOBEL 50 mg, Tabletten Date of registration 26.09.2022 Original/Generic Generic Introduction of Sequence 26.09.2022 ATC-Classification Vildagliptin (A10BH02) Revision date WHO WHO-DDD Valid until 25.09.2027 Index Therapeuticus (BSV) 07.06.20. Show package size 112 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 41.80 Limitation Yes Limitation text
Deductible 10 % Consumer price 61.90 Feedback FB Daily cost GTIN 7680687500029 Medication Code Synthetika Pharmacode Disponibility
Composition vildagliptinum 50 mg, lactosum 10 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.112 - 0.168 mg, magnesii stearas, pro compresso obducto. Packungsbestandteile Galenic Form Tabletten Active Agent Dose Vildagliptinum 50 mg
BAG: Active Agent Dose Vildagliptinum 50 mg
Inactive agents Dose Carboxymethylamylum Natricum A Cellulosum Microcristallinum Lactosum 10 mg Magnesii Stearas Pro Compresso Obducto
Source Data was imported : 06.10.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
